|
Synonyms: compound 95 [US20240383916]
Compound class:
Synthetic organic
Comment: Durocitinib is the INN for a Janus kinase inhibitor with anti-inflammatory and immunosuppressant potential. Structure provided in WHO INN proposed list 135 (July 2026). The chemical structure is in fact claimed as an allosteric (pseudokinase JH2 domain) inhibitor of the TYK2 Janus kinase isoform, in patents held by Sudo Biosciences [1-2]. Sudo Biosciences have two TYK2 inhibitors in their declared development pipeline; SUDO-550, which is orally bioavailable and brain-penetrant, that proposed for the treatment of neuroinflammatory diseases, and SUDO-286 which is intended for topical application as a treatment for immune-mediated dermatologic conditions. Given the low logP value for this compound it is more likely to be SUDO-286 than SUDO-550, but we cannot be certain until the name-structure is formally disclosed.
Ligand Activity Visualisation ChartsThese are box plot that provide a unique visualisation, summarising all the activity data for a ligand taken from ChEMBL and GtoPdb across multiple targets and species. Click on a plot to see the median, interquartile range, low and high data points. A value of zero indicates that no data are available. A separate chart is created for each target, and where possible the algorithm tries to merge ChEMBL and GtoPdb targets by matching them on name and UniProt accession, for each available species. However, please note that inconsistency in naming of targets may lead to data for the same target being reported across multiple charts. ✖ |
|
|||||||||||||||||||||||||||||||||||
Download 2D Structure ![]() |
|
| Canonical SMILES | Download |
| Isomeric SMILES | Download |
| InChI standard identifier | Download |
| InChI standard key | Download |
Molecular structure representations generated using Open Babel